Polyamines are small, positively-charged molecules involved in several cellular processes, including proliferation 8 , apoptosis 9 , ion channel regulation 10 , DNA conformation 11 , and transcription 12, 13 . The biosynthesis of polyamines is regulated by several enzymes, but the conversion of ornithine into putrescine by ornithine decarboxylase (ODC1) is the bottleneck step 14 . Although early work shows that polyamines are included in virions [15] [16] [17] or facilitate viral replication 18, 19 , their general role in viral infection is not established for RNA viruses 20, 21 . We utilized CHIKV to study the role of polyamines in alphavirus infection. CHIKV titers were significantly reduced (p=0.010) in BHK-21 cells treated for four days with 500 μM DFMO and completely rescued with the addition of exogenous polyamines (Fig. 1a) . The complete phenotypic reversal with exogenous polyamines suggests that DFMO treatment was non-toxic to cells, which we corroborated with viability assays (Supplementary Fig. 1 ). The biogenic polyamines putrescine (Put) and spermidine (Spd) also fully rescued viral titers when added individually, but the polyamine precursor, ornithine (Orn), did not ( Supplementary Fig. 2 ), indicating that the biogenic polyamines are required for robust viral replication. Additionally, CHIKV titers were not enhanced with polyamine treatment alone, indicating that viral replication is maximized with endogenous levels of polyamines ( Supplementary Fig.   3 ). We observed the same phenotype in Aedes albopictus C6/36 cells (Fig. 1b) , primary C57/Bl6 murine embryonic fibroblasts (Fig. 1c) , and green monkey kidney Vero-E6 cells (Fig. 1d) . For Sindbis virus (SINV), a closely-related alphavirus, we also observed reduced titers (p=0.002) with DFMO treatment and full rescue with exogenous polyamines (Fig. 1e) .
To confirm that DFMO was reducing polyamine content of treated cells, we performed immunofluorescence with an antibody directed against the biogenic polyamines (spermine, spermidine, and putrescine). BHK-21 cells were treated with DFMO and subsequently infected with CHIKV containing mCherry-tagged nsp3 22 to visualize replication compartments. Upon DFMO treatment, polyamine signal was significantly reduced (Fig. 1f) . With CHIKV infection, no gross difference was noted in polyamine content or localization, and polyamines did not appear to localize precisely with replication compartments. In addition, we directly visualized individual polyamines within untreated or DFMO-treated cells by thin-layer chromatography 23 .
DFMO treatment reduced the total amount of polyamines by approximately 73% (Fig   1g) . As a further confirmation that polyamines are critical to CHIKV replication, we used another ODC1 inhibitor, POB, and observed similar reduction in viral titers (Fig.   1h ).
DFMO-mediated knockdown of viral titers of Semliki Forest Virus relied on a four-day pretreatment 24 . For CHIKV, BHK-21 cells required a 48-hour pretreatment to significantly impact titers (p=0.038), further reduced with 72-or 96-hour pretreatment (Fig. 1i) . This pretreatment was effective at MOI 0.1 and 1, but not 10 for both CHIKV and SINV ( Supplementary Fig. 4 ).
Previous reports described a role for polyamines in herpes simplex virus-1 25 
,
Semliki Forest virus 24 , and hepatitis C virus 26 polymerase activity or RNA replication, and human cytomegalovirus viral assembly 27 . Entry of CHIKV was not impacted, as viral RNA was equivalent (p=0.282) in untreated and DFMO-treated cells at 2 hours post infection (Fig. 2a) . Furthermore, we observed significant inhibition of RNA synthesis for both genomic (p=0.001) and subgenomic (p=0.039) messengers at 24 hours ( Fig. 2a, b) . SINV viral genomes were similarly reduced (Fib. 2c). Although polyamines did not specifically localize with replication compartments as assayed by immunofluorescence ( Fig. 1f) , we asked whether polyamines interact with the To test whether polyamines directly stimulate viral transcription, we measured polymerase activity of both CHIKV and SINV using an in vitro replication (IVR) assay with replication complexes purified from infected cells. Membrane fractions from infected cells were incubated in buffer alone, or buffer containing exogenous polyamines, and polymerization was measured by radionucleotide incorporation after a 3-hour incubation. Samples incubated with polyamines exhibited a significant increase (p=0.021 and p=0.015 for CHIKV and SINV, respectively) in viral RNA synthesis (Fig. 2f, quantitated in Fig. 2g, h) . Similar analyses by qRT-PCR and using the CHIKV replicon system exhibited the same phenotype (Fig. 2i) . In these assays, polyamines could be either directly stimulating the replication complex, or stabilizing templates and nascent genomes. To discern between these hypotheses, viral RNA was incubated in IVR reaction mixtures using membranes from uninfected cells, in the presence or absence of polyamines. Rather than stabilizing viral RNA, we observed significant degradation of viral genomes when incubated with polyamines ( Supplementary Fig. 5 ). Taken together, our data support that polyamines are directly stimulating replication complexes activity.
To understand the sensitivity of CHIKV to DFMO, we infected BHK-21 cells treated with a range of concentrations, from 1 μM to 10 mM and determined the IC 50 to be 35.55 µM (13.05 to 96.08 μM) (Fig. 3a) , which is near the measured plasma concentration in patients treated with oral DFMO 7 . At concentrations above 100 μM, titers were significantly reduced (p<0.002 for each), and no virus was recovered with 10 mM treatment. Similar results were obtained for SINV (Supplementary Fig. 6 ).
Additionally, a 2013 Caribbean strain of CHIKV exhibited significant sensitivity to DFMO that was completely reversed with exogenous polyamine treatment (Fig. 3b) .
While the required pre-exposure treatment may be a viable option for susceptible populations during an outbreak, such as medical professionals treating infected individuals or cohabitants of individuals with communicable diseases, treating the broader population prior to infection is impractical for alphaviruses. To test whether DFMO could reduce viral titers if given after infection, we infected BHK-21 cells with CHIKV at a MOI of 0.0001 (100 viral particles), to mimic a more natural infectious dose, and treated cells with 1 mM DFMO just after infection. CHIKV titers were significantly reduced (p=0.0004) by 32 hours and remained significantly suppressed (p<0.003) through 72 hours (Fig. 3c) . To further investigate potential clinical applications of DFMO, we examined whether it could be combined with another antiviral pharmaceutical, ribavirin 28 . We found that DFMO synergizes with 400 μM ribavirin to significantly reduce CHIKV titers (p=0.038 and 0.0553) in BHK-21 cells beyond either of the antivirals individually (Fig. 3d) .
Polyamines are ubiquitous molecules and as such, we wished to determine whether their requirement, and the effects of DFMO that we observed for alphaviruses, were more broadly applicable. Thus, we explored several RNA viruses from different taxonomic families: the positive-sense coronavirus Middle Eastern respiratory syndrome virus (MCoV , Fig. 3e) ; the positive-sense picornaviruses coxsackievirus B3 (CVB3, Fig. 3f) , poliovirus (PV, Fig. 3g Our results uncover a universal role of polyamines in RNA virus replication and a broad antiviral activity of DFMO against every RNA virus we tested. Although the relatively long pretreatment time required to knockdown endogenous polyamines precludes the use of DFMO in most situations of acute infection, we propose DFMO as a potential preventative or early-response therapeutic in particularly severe outbreaks. Given that DFMO is already clinically approved for treating African sleeping sickness in humans 5, 29 , the rapid implementation of DFMO during serious outbreaks may warrant immediate attention. Specifically, this relatively well-tolerated drug could provide added protection for at-risk populations, such as healthcare workers or family members of afflicted individuals, to prevent spread of disease. 
